| Liver disease and heart failure: Back and forth M Correale, N Tarantino, R Petrucci, L Tricarico, I Laonigro, M Di Biase, ... European journal of internal medicine 48, 25-34, 2018 | 81 | 2018 |
| Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry M Correale, A Mallardi, P Mazzeo, L Tricarico, C Diella, V Romano, ... IJC Heart & Vasculature 27, 100486, 2020 | 49 | 2020 |
| Delirium in heart failure M Correale, M Altamura, R Carnevale, L Tricarico, S Malerba, AM Gallotta, ... Heart Failure Reviews 25, 713-723, 2020 | 22 | 2020 |
| Vascular and metabolic effects of SGLT2i and GLP-1 in heart failure patients M Correale, O Lamacchia, M Ciccarelli, G Dattilo, L Tricarico, ND Brunetti Heart Failure Reviews 28 (3), 733-744, 2023 | 21 | 2023 |
| Switch to SGLT2 inhibitors and improved endothelial function in diabetic patients with chronic heart failure M Correale, P Mazzeo, A Mallardi, A Leopizzi, L Tricarico, M Fortunato, ... Cardiovascular Drugs and Therapy, 1-8, 2022 | 18 | 2022 |
| Direct oral anticoagulants more effective than low-molecular-weight heparin for venous thrombo-embolism in cancer: an updated meta-analysis of randomized trials ND Brunetti, L Tricarico, M Correale, L De Gennaro, F Santoro, R Ieva, ... Journal of Thrombosis and Thrombolysis 50, 305-310, 2020 | 18 | 2020 |
| Infection, atherothrombosis and thromboembolism beyond the COVID-19 disease: what similar in physiopathology and researches M Correale, L Tricarico, M Fortunato, G Dattilo, M Iacoviello, ND Brunetti Aging Clinical and Experimental Research 33, 273-278, 2021 | 17 | 2021 |
| Network meta‐analysis of medical therapy efficacy in more than 90,000 patients with heart failure and reduced ejection fraction V De Marzo, G Savarese, L Tricarico, S Hassan, M Iacoviello, I Porto, ... Journal of internal medicine 292 (2), 333-349, 2022 | 16 | 2022 |
| Liver disease and heart failure. M Correale, L Tricarico, A Leopizzi, A Mallardi, P Mazzeo, S Tucci, ... Panminerva Medica 62 (1), 26-37, 2019 | 14 | 2019 |
| Hospitalization cost reduction with sacubitril-valsartan implementation in a cohort of patients from the Daunia Heart Failure Registry M Correale, I Monaco, A Ferraretti, L Tricarico, G Padovano, ES Formica, ... IJC Heart & Vasculature 22, 102-104, 2019 | 13 | 2019 |
| Efficacy of new medical therapies in patients with heart failure, reduced ejection fraction, and chronic kidney disease already receiving neurohormonal inhibitors: a network … P Ameri, V De Marzo, GB Zoccai, L Tricarico, M Correale, ND Brunetti, ... European Heart Journal-Cardiovascular Pharmacotherapy 8 (8), 768-776, 2022 | 12 | 2022 |
| Electrocardiographic findings and mortality in covid-19 patients hospitalized in different clinical settings M Mele, L Tricarico, E Vitale, A Favia, F Croella, S Alfieri, MD Corbo, ... Heart & Lung 53, 99-103, 2022 | 12 | 2022 |
| New targets in heart failure drug therapy M Correale, L Tricarico, M Fortunato, P Mazzeo, S Nodari, M Di Biase, ... Frontiers in Cardiovascular Medicine 8, 665797, 2021 | 12 | 2021 |
| Echocardiographic score for prediction of pulmonary hypertension at catheterization: the Daunia Heart Failure Registry M Correale, L Tricarico, G Padovano, A Ferraretti, I Monaco, RL Musci, ... Journal of Cardiovascular Medicine 20 (12), 809-815, 2019 | 11 | 2019 |
| Cardiopulmonary exercise test predicts right heart catheterization M Correale, L Tricarico, A Ferraretti, I Monaco, M Concilio, G Padovano, ... European Journal of Clinical Investigation 47 (12), e12851, 2017 | 9 | 2017 |
| Lower major bleeding rates with direct oral anticoagulants in catheter ablation of atrial fibrillation: An updated meta-analysis of randomized controlled studies ND Brunetti, L Tricarico, RR Tilz, CH Heeger, L De Gennaro, M Correale, ... Cardiovascular drugs and therapy 34, 209-214, 2020 | 8 | 2020 |
| Drug-induced pulmonary arterial hypertension: mechanisms and clinical management M Correale, L Tricarico, D Grazioli, ES Formica, R Petrucci, P Persichella, ... Cardiovascular Drugs and Therapy 33, 725-738, 2019 | 8 | 2019 |
| The evolving phenotypes of cardiovascular disease during COVID-19 pandemic M Correale, F Croella, A Leopizzi, P Mazzeo, L Tricarico, A Mallardi, ... Cardiovascular Drugs and Therapy 37 (2), 341-351, 2023 | 7 | 2023 |
| Pharmacological anti-remodelling effects of disease-modifying drugs in heart failure with reduced ejection fraction M Correale, P Mazzeo, L Tricarico, F Croella, M Fortunato, M Magnesa, ... Clinical Drug Investigation 42 (7), 567-579, 2022 | 7 | 2022 |
| Remodelling is inversely proportional to left ventricular dimensions in a real-life population of patients with chronic heart failure after therapy with sacubitril/valsartan M Correale, A Mallardi, L Tricarico, P Mazzeo, A Ferraretti, C Diella, ... Acta Cardiologica 77 (5), 416-421, 2022 | 7 | 2022 |
